To further confirm the role of Nrf2/HMOX1-mediated ferroptosis in PD, Nrf2 inhibitor ML385, Nrf2 agonist Oltipraz, and HMOX1 inhibitor ZNPP, HMOX1 agonist Hemin were administrated. Here, NFE2L2 is linked to Parkinson disease.